Article
Nasal Powder: A Stable, Rapid-Onset Strategy for Systemic Therapy
Summary: Originally published in Inhalation magazine, this article discusses how nasal powder formulations represent a significant stride in drug delivery innovation. With drug developers and approvers evolving to address the unique considerations of nasal drug delivery, nasal powders offer a robust and adaptable platform in the pharmaceutical landscape.
View Now
Article
ARCUS®: A Commercialized Technology Enabling High-Dose, Highly Respirable Powders
Summary: In this article, Dr. Alan Watts, Director of Innovation & Partnerships for Orally Inhaled Products at ×îÐÂÉ«ÇéӰƬ, and Michael Tauber, Senior Director of Pharmaceutical Development at Acorda Therapeutics discuss the requirements and benefits of using spray-dried powders for inhalation, and how ARCUS can be used to successfully bring new inhaled therapies to market.
View Now
Article
Your Perfect Partner for Dry Powder Inhalation
Summary: This article discusses how to successfully develop and manufacture spray-dried pulmonary and nasal powders and how a CDMO partner plays an integral role in the successful development and commercialization of inhalation products.
View Now
Offering Fact Sheet
Nitrosamine Testing Services
Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.
View Now
Webinars
Mitigating the Risk of Pitfalls in Nasal Drug Product Development, Testing and Manufacturing
In this webinar, experts discuss problems common to the development, testing and manufacturing of intranasal drug products, their potential causes, and possible consequences.
View Now
Article
Article: The Key to HPAPI Containment in a Multi-Product Facility
Summary: This article explores the key factors pharmaceutical companies should consider when selecting a CDMO and evaluating its multi-product facility capable of handling HPAPIs to de-risk their programs and bring their products to patients safely.
View Now
Video
Pathways for Pulmonary Delivery
Summary: Discover how ×îÐÂÉ«ÇéӰƬ, a specialized CDMO, accelerates time to market for inhalation innovators with end-to-end solutions.
View Now
Article
Intranasal Drug Delivery: the Challenges and Opportunities
Summary: In this article, experts discuss how the intranasal route offers advantages like faster absorption and minimal product degradation, but also the complex issues to consider when designing a device that will ensure the efficacy of a particular formulation.
View Now
Article
Spray Drying to Enable New Inhaled Drug Products
Summary: This article, originally published in Inhalation Magazine, discusses process & applications considerations for the spray drying of inhaled powders, considerations for formulating biologics as respirable powders and inhalation for non-respiratory indications.
View Now
Executive Summary
Unraveling the Complexities in Nasal Vaccine Development, Manufacturing, and Device Selection
Summary: In this article experts shared their insights on developing intranasal products and scaling them for commercial supply.
View Now